Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Wondering what do you need to start investing? Discover the essential tools and knowledge required to kickstart your investment journey.
19,065 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
SentinelOne stock has bounced off a rough patch, but is it a buy after stock declines? This guide lays out how to eva...
When a mining stock pops today, investors sit up. Discover the drivers behind SSR Mining's rally, what it means for r...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
Hexcel and Rocket Lab USA sit on opposite ends of the aerospace spectrum. One anchors aircraft efficiency; the other ...
A new chapter at Berkshire Hathaway starts with a bold Alphabet bet. This article breaks down why berkshire hathaway'...
SoFi Technologies could be on the verge of a significant rerating as revenue and members keep growing. This guide div...
A viral nine-second clip about two bottles pouring into each other sparked a global conversation. This article transl...
When a big fund trims a REIT stake, investors watch for clues about rental income and stock performance. This article...
If you’re weighing SCHD as a core holding, this guide breaks down what the Schwab U.S. Dividend Equity ETF does, what...
Pangaea (PANL) 2026 earnings narrative hinges on revenue growth, margin expansion, and cash flow strength. This guide...
As Palantir rolls out its Agentic AI Platform, analysts clash over value. This article breaks down the upside, the ri...